News
ODT
--
0.00%
--
OGI, TLRY, APHA among premarket losers
Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -...
Seekingalpha · 04/13 12:31
Odonate Therapeutics (ODT) is Oversold: Can It Recover?
Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Zacks · 04/09 12:17
Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers
Gainers: Auris Medical (EARS) +18%, Prometheus Biosciences (RXDX) +15%, Crinetics Pharmaceuticals (CRNX) +13%, Genprex (GNPX) +12%, Fortress Biotech (FBIO) +12%.Losers: Endo International (ENDP) -10%, Odonate Therapeutics (ODT) -9%, Otonomy (OTIC) -8%, Bro...
Seekingalpha · 04/08 15:05
Is Odonate Therapeutics (NASDAQ:ODT) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Simply Wall St. · 04/08 11:26
GEO, OCGN, SOS and CXW among midday movers
Gainers: Bonso Electronics International (BNSO) +36%.SOS (SOS) +29%.Ouster (OUST) +29%.ION Geophysical (IO) +22%.Odonate Therapeutics (ODT) +20%.Titan Medical (TMDI) +16%.Cocrystal Pharma (COCP) +15%.Ocugen (OCGN) +15%.Pintec Technology (PT) +13%.Frequency...
Seekingalpha · 04/07 16:44
Odonate Therapeutics, Ocugen leads healthcare gainers; FibroGen, Homology Medicines among major losers
Gainers: Odonate Therapeutics (ODT) +34%, Ocugen (OCGN) +24%, Titan Medical (TMDI) +15%, Frequency Therapeutics (FREQ) +14, 9 Meters Biopharma (NMTR) +10%%.Losers: FibroGen (FGEN) -39%, Homology Medicines (FIXX) -18%, Galectin Therapeutics (GALT) -14%, Bro...
Seekingalpha · 04/07 15:01
AKBA, SYBX, FGEN and FIXX among after-hours movers
Gainers: [[AKBA]] +12.1%. [[SYBX]] +7.1%. [[ARDX]] +5.2%. [[ODT]] +4.9%. [[BYND]] +4.2%.Losers: [[FGEN]] -29.2%. [[FIXX]] -10.2%. [[MAXN]] -6.8%. [[IONS]] -5.8%. [[OM]] -5.4%.
Seekingalpha · 04/06 21:39
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The earnings news flow was confined to micro- and small-cap companies. Five biopharma companies listed their shares on the Nasd...
Benzinga · 03/27 14:40
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 25)
Benzinga · 03/26 11:28
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 24)
Benzinga · 03/25 11:58
Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?
Zacks.com · 03/24 17:26
The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 23)
Benzinga · 03/24 12:59
IONS, GNUS, UPST and FNKO among midday movers
Gainers: Dolphin Entertainment (DLPN) +163%.Benitec Biopharma (BNTC) +88%.Liquid Media (YVR) +51%.Takung Art (TKAT) +35%.Evolve Transition Infrastructure (SNMP) +27%.Genius Brands International (GNUS) +17%.The ONE Group Hospitality (STKS) +17%.Glory Star N...
Seekingalpha · 03/23 16:41
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 22)
Benzinga · 03/23 12:18
Why GRPN Stock And ODT Stock Are Trading Lower Today
Groupon Inc (NASDAQ: GRPN) shares are trading lower Monday after the company announced a proposed private offering of $200 million of convertible senior notes.
Benzinga · 03/22 19:45
Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations
Shares of Odonate Therapeutics Inc. undefined plummeted 79.0% in active afternoon trading Monday, after the pharmaceutical company said it will wind down...
MarketWatch · 03/22 18:36
Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; Dyadic International Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.37% to 32,747.07 while the NASDAQ rose 1.68% to 13,436.88. The S&P also rose, gaining 0.91% to 3,948.67.
Benzinga · 03/22 18:33
DJ Odonate Therapeutics Stock Plummets Toward Record Low After Plan To 'wind Down' Operations -- MarketWatch
Dow Jones · 03/22 17:36
As Odonate plunges after abandoning lead program, Jefferies cuts rating, price target
Following this morning's announcement that it was abandoning tesetaxel for breast cancer following negative feedback from the FDA in a pre-NDA meeting, Jefferies analyst Michael Yee has cut shares of Odonate
Seekingalpha · 03/22 16:59
Webull provides a variety of real-time ODT stock news. You can receive the latest news about Odonate Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About ODT
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).